Status
Conditions
Treatments
About
The purpose is to determine intrinsic properties of various immunohistochemical markers (FVIIIra, CD15, CD30, tryptase, TNFα, IL-1β, TGFα et TGFβ1) for diagnosis of vital wound, alone and in association (evaluation of sensibility with surgery wounds and evaluation of specificity with post-mortem wounds).
Secondary purposes are to measure the minimum time to obtain a positive labeling in vital wounds, and to evaluate inter-observer reproducibility of vitality diagnosis with different markers. Expression of microRNA miR 9, miR 21 et miR 198 will be also studied.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Alive persons:
Deceased persons:
Exclusion criteria
Alive persons:
Deceased persons:
57 participants in 2 patient groups
Loading...
Central trial contact
Laurent MARTRILLE
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal